These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
642 related articles for article (PubMed ID: 18674538)
1. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538 [TBL] [Abstract][Full Text] [Related]
2. Autoimmune-mediated intestinal inflammation-impact and regulation of antigen-specific CD8+ T cells. Westendorf AM; Fleissner D; Deppenmeier S; Gruber AD; Bruder D; Hansen W; Liblau R; Buer J Gastroenterology; 2006 Aug; 131(2):510-24. PubMed ID: 16890605 [TBL] [Abstract][Full Text] [Related]
3. CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice. Haile LA; Gamrekelashvili J; Manns MP; Korangy F; Greten TF J Immunol; 2010 Jul; 185(1):203-10. PubMed ID: 20525890 [TBL] [Abstract][Full Text] [Related]
4. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis. Zierden M; Kühnen E; Odenthal M; Dienes HP Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127 [TBL] [Abstract][Full Text] [Related]
5. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314 [TBL] [Abstract][Full Text] [Related]
6. Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells. Salem ML; Kadima AN; El-Naggar SA; Rubinstein MP; Chen Y; Gillanders WE; Cole DJ J Immunother; 2007 Jan; 30(1):40-53. PubMed ID: 17198082 [TBL] [Abstract][Full Text] [Related]
8. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration. Janicki CN; Jenkinson SR; Williams NA; Morgan DJ Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769 [TBL] [Abstract][Full Text] [Related]
9. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167 [TBL] [Abstract][Full Text] [Related]
10. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Yang R; Cai Z; Zhang Y; Yutzy WH; Roby KF; Roden RB Cancer Res; 2006 Jul; 66(13):6807-15. PubMed ID: 16818658 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine. Ko HJ; Lee JM; Kim YJ; Kim YS; Lee KA; Kang CY J Immunol; 2009 Feb; 182(4):1818-28. PubMed ID: 19201833 [TBL] [Abstract][Full Text] [Related]
13. Intestinal epithelial antigen induces CD4+ T cells with regulatory phenotype in a transgenic autoimmune mouse model. Westendorf AM; Bruder D; Hansen W; Buer J Ann N Y Acad Sci; 2006 Aug; 1072():401-6. PubMed ID: 17057222 [TBL] [Abstract][Full Text] [Related]